NBIX - Neurocrine Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
675,569
451,240
161,626
15,000
19,769
Cost of Revenue
6,500
4,889
1,254
-
0
Gross Profit
669,069
446,351
160,372
-
19,769
Operating Expenses
Research Development
301,805
160,524
121,827
94,291
81,491
Selling General and Administrative
321,831
248,932
169,906
68,081
32,480
Total Operating Expenses
623,636
409,456
291,733
162,372
113,971
Operating Income or Loss
45,433
36,895
-131,361
-147,372
-94,202
Interest Expense
31,596
30,530
19,523
-
-
Total Other Income/Expenses Net
12,875
15,476
8,342
3,444
5,273
Income Before Tax
26,712
21,841
-142,542
-141,090
-88,929
Income Tax Expense
5,622
730
-
-
-
Income from Continuing Operations
21,090
21,111
-142,542
-141,090
-88,929
Net Income
21,090
21,111
-142,542
-141,090
-88,929
Net Income available to common shareholders
21,090
21,111
-142,542
-141,090
-88,929
Reported EPS
Basic
-
0.23
-1.62
-1.63
-1.05
Diluted
-
0.22
-1.62
-1.63
-1.05
Weighted average shares outstanding
Basic
-
90,235
88,089
86,713
84,496
Diluted
-
95,386
88,089
86,713
84,496
EBITDA
-
56,395
-120,619
-145,919
-94,202